| Symbol |
Name |
|
ABHD5
|
abhydrolase domain containing 5
|
|
ACOT13
|
acyl-CoA thioesterase 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGRP
|
agouti related neuropeptide
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
APOC1
|
apolipoprotein C-I
|
|
BCO2
|
beta-carotene oxygenase 2
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CES1
|
carboxylesterase 1
|
|
CHKA
|
choline kinase alpha
|
|
CRBN
|
cereblon
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
EGR1
|
early growth response 1
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FADS2
|
fatty acid desaturase 2
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FFAR4
|
free fatty acid receptor 4
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGL1
|
fibrinogen-like 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXO1
|
forkhead box O1
|
|
G0S2
|
G0/G1 switch 2
|
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPR12
|
G protein-coupled receptor 12
|
|
GPRC6A
|
G protein-coupled receptor, class C, group 6, member A
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GYS2
|
glycogen synthase 2 (liver)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HRH1
|
histamine receptor H1
|
|
HSD3B7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
|
|
IL10
|
interleukin 10
|
|
INS
|
insulin
|
|
JUND
|
jun D proto-oncogene
|
|
KMT2B
|
lysine (K)-specific methyltransferase 2B
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LIPI
|
lipase, member I
|
|
LPIN1
|
lipin 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MC4R
|
melanocortin 4 receptor
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MGLL
|
monoglyceride lipase
|
|
MIR122
|
microRNA 122
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA5
|
nuclear receptor coactivator 5
|
|
NEGR1
|
neuronal growth regulator 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OSMR
|
oncostatin M receptor
|
|
PANK1
|
pantothenate kinase 1
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PEX11A
|
peroxisomal biogenesis factor 11 alpha
|
|
PLIN2
|
perilipin 2
|
|
PLIN5
|
perilipin 5
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRLH
|
prolactin releasing hormone
|
|
PROX1
|
prospero homeobox 1
|
|
RETN
|
resistin
|
|
RGN
|
regucalcin
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCP2
|
sterol carrier protein 2
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERTAD2
|
SERTA domain containing 2
|
|
SESN2
|
sestrin 2
|
|
SIK3
|
SIK family kinase 3
|
|
SIRT3
|
sirtuin 3
|
|
SIRT7
|
sirtuin 7
|
|
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5
|
|
SLC5A10
|
solute carrier family 5 (sodium/sugar cotransporter), member 10
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SSFA2
|
sperm specific antigen 2
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STEAP4
|
STEAP family member 4
|
|
TLR4
|
toll-like receptor 4
|
